"Gold Dagger" to replace Viagra in China?
posted by Lawrence B. Ebert at 9:13 PM
Saturday, November 01, 2014
About Me
- Name: Lawrence B. Ebert
I'm a patent lawyer located in central New Jersey. I have a J.D. from the University of Chicago and a Ph.D. from Stanford University, where I studied graphite intercalation compounds at the Center for Materials Research. I worked at Exxon Corporate Research in areas ranging from engine deposits through coal and petroleum to fullerenes. An article that I wrote in The Trademark Reporter, 1994, 84, 379-407 on color trademarks was cited by Supreme Court in Qualitex v. Jacobson, 514 US 159 (1995) and the methodology was adopted in the Capri case in N.D. Ill. An article that I wrote on DNA profiling was cited by the Colorado Supreme Court (Shreck case) and a Florida appellate court (Brim case). I was interviewed by NHK-TV about the Jan-Hendrik Schon affair. I am developing ipABC, an entity that combines rigorous IP analytics with study of business models, to optimize utilization of intellectual property. I can be reached at C8AsF5 at yahoo.com.
Previous Posts
- Further discussion of WARF stem cell patent, US 7,...
- Consumer Watchdog / PubPat seek Supreme Court revi...
- Teva optimistic about outcome in Teva v. Sandoz (!)
- Harvard's terminal disclaimer argument fails at CAFC
- More on Rader's "death squads"
- Google Doodle tribute to Jonas Salk questioned in ...
- Google has obtained 14% of US track 1 patents that...
- 60 Minutes on October 26, 2014
- On government involvement in patent acquisition
- Apple after jury verdict: GPNE is nothing more th...
0 Comments:
Post a Comment
<< Home